Skip to main content
Clinical Trials/RBR-2t56nz
RBR-2t56nz
Completed
未知

Double Blind Randomized Trial for L-arginine Effectineness study as a coadjuvante therapeutic protocol in the treatment of Sickle Cell Anemia

niversidade Federal do Ceará0 sitesStarted: October 24, 2017Last updated:

Overview

Phase
未知
Status
Completed
Sponsor
niversidade Federal do Ceará

Overview

Brief Summary

No summary available.

Study Design

Study Type
Intervention

Eligibility Criteria

Inclusion Criteria

  • Adult patients volunteers between 18 and 80 years with sickle cell anemia; both genders; in use of hydroxiurea from 500mg per day; baseline

Exclusion Criteria

  • Patients who do not have sickle cell anemia; Patients who refuse to participate in the study not signing the ethic term; those who have had transfusional therapy in the last three months; patients using iron chelator and antioxidant vitamins; patients smokers and drinkers; pregnant or with diabetes mellitus or with some picture of renal or hepatic insufficiency

Investigators

Sponsor
niversidade Federal do Ceará

Similar Trials